Williams Kristen Marie's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Jun 5, 2026
- Accession no.
- 0001628280-26-041330
- Filed
- Jun 5, 2026
- Trade date
- Jun 3-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $228.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williams Kristen MarieCIK 0001296965 | Officer (Chief Administrative Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | FTax withholdingDisposed | −8,528 | $22.32 | −$190,344.96 | 177,321 | Direct | |
| Jun 4, 2026 | Common Stock | SSaleDisposed | −10,259 | $22.27 | −$228,467.93 | 167,062 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.